Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study
Inês Laginha(Charité - Universitätsmedizin Berlin), Jan M. Schwab(The Ohio State University Wexner Medical Center), Axel Ekkernkamp(Unfallkrankenhaus Berlin), Claudia Druschel(Charité - Universitätsmedizin Berlin), Monica Killig(German Rheumatism Research Centre), Harald Prüß(German Center for Neurodegenerative Diseases), Rick C. Hellmann(Charité - Universitätsmedizin Berlin), Ralf Watzlawick(Charité - Universitätsmedizin Berlin), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Benedikt Brommer(CellAct Pharma (Germany)), Vieri Failli(Centre National de la Recherche Scientifique), Chiara Romagnani(German Rheumatism Research Centre), Klaus‐Dieter Schaser(NIHR Oxford Musculoskeletal Biomedical Research Centre), Andreas Niedeggen(Diagnostic and Treatment Centre Berlin), Erik Prilipp(Diagnostic and Treatment Centre Berlin), Christian Meisel(University of Zurich), Ulrike Grittner(Charité - Universitätsmedizin Berlin), Marcel A. Kopp(Charité - Universitätsmedizin Berlin), Sophie K. Piper(Charité - Universitätsmedizin Berlin), Thomas Liebscher
Cited by 17
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
|The Lancet Neurology|2009|581